PETERSON RABEL: Open Payments
NPI 1417435009 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 54 payments from 9 companies in 2025. Trend: 2023 $489 · 2024 $890 · 2025 $1,428
Food & beverage: $1,428
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $398 |
| Alkermes, Inc. | 14 | $287 |
| Otsuka America Pharmaceutical, Inc. | 11 | $229 |
| Neurocrine BioSciences, Inc. | 2 | $164 |
| Lundbeck LLC | 7 | $162 |
| Janssen Pharmaceuticals, Inc | 2 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Luye Pharma (USA) Ltd. | 2 | $45 |
| ABBVIE INC. | 1 | $30 |
Products named: COBENFY, ABILIFY ASIMTUFII, ARISTADA, INGREZZA, INVEGA SUSTENNA, UZEDY, ERZOFRI EXTENDED-RELEASE, VRAYLAR.
Industry payments across NY — which companies pay providers there.
